Connect Biopharma Holdings Limited
CNTB
Price:
$1
Market Cap:
$55.25M
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmu...[Read more]
Industry
Biotechnology
IPO Date
2021-03-19
Stock Exchange
NASDAQ
Ticker
CNTB
PE Ratio
[-2.56]
ROE
[7.21%]
Current Ratio
[12.04]
Dividend Yield
[0%]
Enterprise Value
[-54594968.00]
Dividend History
The ROE as of November 2024 (TTM) for Connect Biopharma Holdings Limited (CNTB) is 7.21%
According to Connect Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current ROE is 7.21%. This represents a change of 318.06% compared to the average of 1.72% of the last 4 quarters.
Connect Biopharma Holdings Limited (CNTB) Historical ROE (quarterly & annually)
How has CNTB ROE performed in the past?
The mean historical ROE of Connect Biopharma Holdings Limited over the last ten years is 3.84%. The current 7.21% ROE has changed 87.48% with respect to the historical average. Over the past ten years (40 quarters), CNTB's ROE was at its highest in in the March 2024 quarter at 3.46%. The ROE was at its lowest in in the June 2021 quarter at -45.25%.
Average
3.84%
Median
12.55%
Minimum
-75.29%
Maximum
76.62%
Connect Biopharma Holdings Limited (CNTB) ROE by Quarter and Year
Discovering the peaks and valleys of Connect Biopharma Holdings Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 76.62%
Minimum Annual Increase = -334.59%
Minimum Annual ROE = -75.29%
| Year | ROE | Change |
|---|---|---|
| 2023 | -58.89% | -334.59% |
| 2022 | 25.10% | -133.34% |
| 2021 | -75.29% | -198.26% |
| 2020 | 76.62% | 38.03% |
| 2019 | 55.51% | Infinity% |
Connect Biopharma Holdings Limited (CNTB) Average ROE
How has CNTB ROE performed in the past?
The current ROE of Connect Biopharma Holdings Limited (CNTB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-36.36%
5-year avg
4.61%
10-year avg
3.84%
Connect Biopharma Holdings Limited (CNTB) ROE vs. Peers
How is CNTB’s ROE compared to its peers?
Connect Biopharma Holdings Limited’s ROE is less than Assembly Biosciences, Inc. (0%), greater than Neoleukin Therapeutics, Inc. (-121.46%), greater than Instil Bio, Inc. (-8.54%), greater than CytomX Therapeutics, Inc. (-37.44%), greater than Achilles Therapeutics plc (-41.34%), greater than NextCure, Inc. (-54.57%), greater than Nuvation Bio Inc. (-62.50%), greater than Ovid Therapeutics Inc. (-108.68%), greater than null (-39.24%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $95.60M | |
| -121.46% | $8.20M | |
| -8.54% | $170.65M | |
| -37.44% | $69.65M | |
| -41.34% | $43.57M | |
| -54.57% | $33.33M | |
| -62.50% | $942.39M | |
| -108.68% | $74.56M | |
| -39.24% | $0 |
Build a custom stock screener for Connect Biopharma Holdings Limited (CNTB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Connect Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Connect Biopharma Holdings Limited (CNTB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Connect Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Connect Biopharma Holdings Limited's ROE?
How is the ROE calculated for Connect Biopharma Holdings Limited (CNTB)?
What is the highest ROE for Connect Biopharma Holdings Limited (CNTB)?
What is the 3-year average ROE for Connect Biopharma Holdings Limited (CNTB)?
What is the 5-year average ROE for Connect Biopharma Holdings Limited (CNTB)?
How does the current ROE for Connect Biopharma Holdings Limited (CNTB) compare to its historical average?